Kenya High Court Rules Anti-Counterfeit Act Unjustly Limits Generic Drugs
This article was originally published in PharmAsia News
Executive Summary
A Kenya court has ruled the nation’s four-year-old Anti-Counterfeit Act excessively limits access to generic drugs and other affordable and essential medicines.